VistaGen Therapeutics Inc
NASDAQ:VTGN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Wall Street
Price Targets
VTGN Price Targets Summary
VistaGen Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for VTGN is 3.8 USD with a low forecast of 0.91 USD and a high forecast of 12.6 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VTGN's stock price target?
Price Target
3.8
USD
According to Wall Street analysts, the average 1-year price target for VTGN is 3.8 USD with a low forecast of 0.91 USD and a high forecast of 12.6 USD.
What is VistaGen Therapeutics Inc's Revenue forecast?
Projected CAGR
424%
For the last 13 years the compound annual growth rate for VistaGen Therapeutics Inc's revenue is -8%. The projected CAGR for the next 3 years is 424%.
